Intrexon Corp., 10% Owner at ZIOPHARM ONCOLOGY INC (ZIOP), bought 2,857,143 shares at $3.50 ($10.0M) on 2013-10-29, disclosed to the SEC on 2013-10-31.
Open-market purchase of $10.0M ZIOP by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| Filing → |
| AQB | BUY | 2018-01-19 | $10.0M | — | Filing → |
| FCSC | BUY | 2017-12-13 | $4.2M | — | Filing → |
| AQB | BUY | 2017-01-20 | $25.0M | — | Filing → |